Want to see JP:4595 full AI Analyst Report?

Mizuho Medy Co., Ltd. (4595) Price & Analysis

0 Followers

4595 Stock Chart & Stats

¥1753.00

¥40.00(2.73%)

At close: Jan 08 4:00 PM EST

¥1753.00

¥40.00(2.73%)

Day’s Range― - ―

52-Week Range¥1,582.00 - ¥1,930.00

Previous CloseN/A

Volume223.50K

Average Volume (3M)88.20K

Market Cap

¥32.19B

Enterprise Value¥18.35K

Total Cash (Recent Filing)¥13.06B

Total Debt (Recent Filing)¥0.00

Price to Earnings (P/E)10.0

Beta0.40

Next Earnings

Nov 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield5.92%

Share Statistics

EPS (TTM)169.41

Shares Outstanding19,051,200

10 Day Avg. Volume77,390

30 Day Avg. Volume88,203

Financial Highlights & Ratios

PEG Ratio-1.03

Price to Book (P/B)1.74

Price to Sales (P/S)2.88

P/FCF Ratio19.09

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)152.2

Revenue Forecast (FY)¥10.90B

Bulls Say, Bears Say

Bulls Say

High ProfitabilitySustained ~30% net margins indicate durable pricing power or cost advantage in its specialty/generic niche. High margins support ongoing reinvestment, R&D and dividend capacity, giving the company long-term earnings resilience versus lower‑margin peers.

Debt-free Balance SheetA zero‑debt balance sheet provides structural financial flexibility: low solvency risk, capacity to fund capex or M&A from internal resources, and resilience through industry cycles. This enhances long‑term stability and strategic optionality.

Consistent Free Cash FlowHistorically strong free cash flow conversion supports sustainable dividends, internal investment and balance sheet strength. Reliable cash generation underpins valuation-insensitive capital allocation and reduces dependence on external financing over time.

Bears Say

Deteriorating Cash Conversion (2025)A recent drop where operating cash flow lags net income signals weaker earnings quality and potential working capital or collection stress. If persistent, this reduces free cash available for investment and dividends and raises cyclicality of reported profits.

Choppy Revenue And Margin NormalizationVolatile revenue trends and normalization from peak margins suggest less predictable top-line momentum and a reduced earnings ceiling versus prior years. This structural variability can limit durable earnings growth and complicate long‑range planning.

Declining Returns On EquityA multi-year decline in ROE signals weakening capital efficiency—possibly from tougher market dynamics or mix shifts. Lower ROE can constrain shareholder return potential and indicate the company may need strategic action to restore past profitability levels.

4595 FAQ

What was Mizuho Medy Co., Ltd.’s price range in the past 12 months?

Mizuho Medy Co., Ltd. lowest stock price was ¥1582.00 and its highest was ¥1930.00 in the past 12 months.

What is Mizuho Medy Co., Ltd.’s market cap?

Mizuho Medy Co., Ltd.’s market cap is ¥32.19B.

When is Mizuho Medy Co., Ltd.’s upcoming earnings report date?

Mizuho Medy Co., Ltd.’s upcoming earnings report date is Nov 06, 2026 which is in 54 days.

How were Mizuho Medy Co., Ltd.’s earnings last quarter?

Mizuho Medy Co., Ltd. released its earnings results on Aug 12, 2026. The company reported ¥11.61 earnings per share for the quarter.

Is Mizuho Medy Co., Ltd. overvalued?

According to Wall Street analysts Mizuho Medy Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Mizuho Medy Co., Ltd. pay dividends?

Mizuho Medy Co., Ltd. pays a Semiannually dividend of ¥50 which represents an annual dividend yield of 5.92%. See more information on Mizuho Medy Co., Ltd. dividends here

What is Mizuho Medy Co., Ltd.’s EPS estimate?

Mizuho Medy Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Mizuho Medy Co., Ltd. have?

Mizuho Medy Co., Ltd. has 19,051,200 shares outstanding.

What happened to Mizuho Medy Co., Ltd.’s price movement after its last earnings report?

Mizuho Medy Co., Ltd. reported an EPS of ¥11.61 in its last earnings report. Following the earnings report the stock price went down -0.82%.

Which hedge fund is a major shareholder of Mizuho Medy Co., Ltd.?

Currently, no hedge funds are holding shares in JP:4595

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Mizuho Medy Co., Ltd.

Established in 1977 and headquartered in Tosu, Japan, Mizuho Medy Co.,Ltd. specializes in the research, development, production, and distribution of in-vitro diagnostic solutions, complemented by scientific and technical information services. While its primary operations are in Japan, the company maintains an international presence through import and export activities, extending its reach to countries including the United States, Belgium, Finland, the Netherlands, Taiwan, and Thailand. Its extensive product lineup includes a wide array of immunoassay test kits designed for detecting pathogens such as influenza viruses, RS virus, human metapneumovirus, Streptococcus pneumoniae, Legionella, Mycoplasma pneumoniae, adenovirus, rotavirus, norovirus, and Group A streptococcus. Additionally, Mizuho Medy offers kits for pregnancy, ovulation, and fecal occult blood screening. The company also provides advanced tools like gene analysis instruments and specialized diagnostic kits for SARS-CoV-2 detection and Mycoplasma pneumoniae nucleic acid analysis.